Novartis CEO says U.S. rebate plan will return cash to patients
February 06, 2019 at 17:42 PM EST
Novartis AG Chief Executive Vas Narasimhan said his company's prescription drug prices have been "flat to negative" over the last three years, and directed blame for high costs for U.S. patients on industry middlemen that manage drug benefits.